Prospective Registry of ihtDEStiny® Coronary Stent in Regular PCI Practice

NCT04899141 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2026-02-17

No results posted yet for this study

Summary

Prospective registry intended to evaluate clinical outcomes of ihtDEStiny drug eluting coronary stent.

Conditions

Interventions

DEVICE

Percutaneous Coronary Intervention

stenting with the ihtDEStiny® sirolimus eluting stent

Sponsors & Collaborators

  • Fundación EPIC

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-29
Primary Completion
2028-04-01
Completion
2028-05-01

Countries

  • Portugal
  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04899141 on ClinicalTrials.gov